JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 3, 2005; DOI: 10.1124/jpet.105.093062


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.093062v1
316/2/520    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forkert, P.-G.
Right arrow Articles by Ghanayem, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forkert, P.-G.
Right arrow Articles by Ghanayem, B. I.


Received for publication July 29, 2005.
Revised November 1, 2005.
Accepted for publication November 2, 2005.

Pulmonary Bronchiolar Cytotoxicity and Formation of Dichloroacetyl Lysine Protein Adducts in Mice Treated with Trichloroethylene

Poh-Gek Forkert 1*, Brandie Millen 2, Lawrence H. Lash 3, David A. Putt 3, Burhan I. Ghanayem 4

1 Queen's University - Ontario 2 Queen's University-Ontario 3 Wayne State University School of Medicine 4 National Institutes of Health

* Address correspondence to: E-mail: forkertp{at}post.queensu.ca

Abstract

This study was undertaken to test the hypothesis that bronchiolar damage induced by trichloroethylene (TCE) is associated with bioactivation within the Clara cells with involvement of CYP2E1 and CYP2F2. Histopathology confirmed dose-dependent Clara cell injury and disintegration of the bronchiolar epithelium in CD-1 mice treated with TCE doses of 500 to 1000 mg/kg, i.p. Immunohistochemical studies, using an antibody that recognizes dichloroacetyl lysine adducts, revealed dose- dependent formation of adducts in the bronchiolar epithelium. Localization of dichloroacetyl adducts in the Clara cells coincided with damage to this cell type in TCE-treated mice. Pretreatment of CD-1 mice with diallyl sulfone, an inhibitor of CYP2E1 and CYP2F2, abrogated formation of the dichloroacetyl adducts and protected against TCE-induced bronchiolar cytotoxicity. Treatment of wild-type and CYP2E1-null mice with TCE (750 mg/kg, i.p.) also elicited bronchiolar damage that correlated with formation of adducts in the Clara cells. Immunoblotting, using lung microsomes from TCE-treated CD- 1 mice, showed dose-dependent production of dichloroacetyl adducts that co-migrated with CYP2E1 and CYP2F2. However, TCE treatment resulted in loss of immunoreactive CYP2E1 and CYP2F2 proteins and p- nitrophenol hydroxylation, a catalytic activity associated with both P450 enzymes. The TCE metabolite, chloral hydrate, was formed in incubations of TCE with lung microsomes from CD-1, wild-type and CYP2E1-null mice. The levels were higher in CD-1 than in either wild- type or CYP2E1-null mice, although levels were higher in CYP2E1-null than in wild-type mice. These findings supported the contention that TCE bioactivation within the Clara cells, predominantly involving CYP2F2, correlated with bronchiolar cytotoxicity in mice.


Key words: CYP2E1, CYP2F2, Clara cells, chloral hydrate, diallyl sulfone, protein adducts


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
P.-G. Forkert, M. Kaufmann, G. Black, R. Bowers, H. Chen, K. Collins, A. Sharma, and G. Jones
Oxidation of Vinyl Carbamate and Formation of 1,N6-Ethenodeoxyadenosine in Murine Lung
Drug Metab. Dispos., May 1, 2007; 35(5): 713 - 720.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Kim and B. I. Ghanayem
Comparative Metabolism and Disposition of Trichloroethylene in Cyp2e1-/-and Wild-Type Mice
Drug Metab. Dispos., December 1, 2006; 34(12): 2020 - 2027.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.